Publication:
Steps in the Pathogenesis of Multiple Sclerosis - I: From Neuroinflammation to Neurodegeneration

dc.authorwosidKarabudak, Rana/Hjh-2490-2023
dc.authorwosidAydin, Ömer/Jpk-2999-2023
dc.contributor.authorKurne, Asli
dc.contributor.authorKarabudak, Rana
dc.contributor.authorAydin, Omer Faruk
dc.date.accessioned2025-12-11T00:42:27Z
dc.date.issued2006
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Kurne, Asli; Karabudak, Rana] Hacettepe Univ, Tip Fak, Norol Anabilim Dali Noroimmunol Unitesi, TR-06100 Ankara, Turkey; [Aydin, Omer Faruk] Ondokuz Mayis Univ, Tip Fak, Cocuk Norolojisi Bilim Dali, Samsun, Turkeyen_US
dc.description.abstractInflammation has been described as a deleterious factor in MS immunopathogenesis for a long time. However, recent studies have proved the neuronal protective and efficacious effects of inflammation. Inflammation in the brain is a double-edged process that may be beneficial in promoting homeostasis and repair, but can also result in tissue injury through the damaging potential of inflammatory mediators. Control mechanisms that minimize the extent of the inflammatory reaction are necessary in order to preserve brain architecture and restore function. The end result of the inflammatory process, neurotoxicity and/or neuroprotection, is a function of the fine balance between the two cellular systems and of the complex signaling relationships between anti-inflammatory neuroprotective factors. In central nervous system inflammation the extent of tissue injury depends on both native and adaptive elements of the immune system. Besides, inflammation is not limited with the invasion of exogeneus cells infiltrating from the blood brain barrier. Astrocytes and microglial cells as being endogeneous also play an important role in the process. Secondary inflammatory mediators from these cells trigger the unique local inflammation of central nervous system. In the active MS plaques distinct cytokines and chemokines have been determined. Conclusion: Inflammation has different aspects and some proof of beneficial roles can be summarized: Before the clinical signs of /during the experimental allergic encephalomyelitis (EAE) the presence of IFN-gamma has been shown as a limitting factor for the progression, the delivery of antiIFN-g monoclonal antibodies have increased the morbidity in EAE. CD4+ T cells stimulate microglial cells to secrete some mediators as interleukin E2 that can supress IL-12 and the same cells can also secrete neruprotective factors as brain derived neurotrophic factor. Another group of cells, macrophages trigger remyelinization by clearing myelin debris. This review discusses about the contradictory effects of inflammation on the immunopathogenesis of multiple sclerosis. It outlines the cells responsible for the inflammatory cascade, both beneficial and detrimental effects of inflammation on myelin and axonal integrity and additional relation for demyelination and axonal transsection.en_US
dc.description.woscitationindexEmerging Sources Citation Index
dc.identifier.endpage13en_US
dc.identifier.issn1301-062X
dc.identifier.issn1309-2545
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ4
dc.identifier.startpage5en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/38621
dc.identifier.volume12en_US
dc.identifier.wosWOS:000217381300001
dc.language.isotren_US
dc.publisherTurkish Neurological Societyen_US
dc.relation.ispartofTurkish Journal of Neurologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMultiple Sclerosisen_US
dc.subjectImmunopathogenesisen_US
dc.subjectInflammationen_US
dc.titleSteps in the Pathogenesis of Multiple Sclerosis - I: From Neuroinflammation to Neurodegenerationen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files